Clinical applications of concentrated growth factors membrane for sealing the socket in alveolar ridge preservation: a randomized controlled trial

Yumeng Liu, Xiaoming Li, Changwei Jiang, Huiying Guo, Guisheng Luo, Yangyang Huang, Changyong YuanInternational Journal of Implant Dentistry 2022 · DOI

Abstract

The purpose of this study was to evaluate the efficacy of concentrated growth factor (CGF) membrane for the sealing of alveolar socket in alveolar ridge preservation (ARP). A total of 22 patients with 24 alveolar sockets were recruited and divided randomly into CGF group and Bio-Gide collagen membrane group. The soft tissue wound healing rate was calculated using intraoral scanner at 3, 7, and 14 days after ARP, and the bone resorption volume at 1, 3, and 5 mm below the alveolar ridge was measured by CBCT at 6 months postoperation. The keratinized gingival width was also measured before and 6 months after ridge preservation. In terms of soft tissue healing rate, the CGF group exhibited significant higher than that of Bio-Gide group at both 7 and 14 days after surgery (P < 0.05). However, there was no significantly different in bone resorption rate and the width of keratinized gingival after 6 months (P > 0.05). Therefore, the use of CGFs membranes for wound closure in ARP is a reliable method, but more clinical data are needed to prove it.

Introduction

Following tooth extraction, the alveolar ridge naturally undergoes significant resorption, often losing 32–63% of its horizontal width within six to seven months. This bone loss complicates subsequent dental implant placement and frequently necessitates invasive bone grafting procedures. Alveolar Ridge Preservation (ARP) aims to mitigate this loss by filling the socket with graft material and sealing it with a membrane.

While commercial collagen membranes (e.g., Bio-Gide) are considered the gold standard, they are expensive and animal-derived. This randomized controlled trial investigates the efficacy of Concentrated Growth Factor (CGF)—an autogenous membrane derived from the patient's own blood—as a cost-effective, biologically active alternative for socket sealing.

Methods and Materials

The study involved 22 patients (24 sockets) randomly assigned to either a CGF group or a Bio-Gide group. All sockets were grafted with Bio-Oss Collagen. The CGF membranes were prepared via centrifugation of the patient's blood, creating a dense fibrin matrix rich in growth factors like VEGF and TGF-β1.

Objective Healing Measurement

A novel aspect of this study was the use of 3D digital technology to quantify healing. Instead of subjective visual assessments, the researchers employed an intraoral scanner and Geomagic software to calculate the precise wound healing rate by measuring the surface area of the open wound at 3, 7, and 14 days post-surgery.

3D digital model generated from intraoral scanning used to calculate the soft tissue wound healing rate.

Additionally, Cone-beam computed tomography (CBCT) was used to measure bone resorption at 1, 3, and 5 mm below the ridge at six months. During implant placement, soft tissue samples were collected for histological analysis of micro-vessel density (MVD) using the CD31 marker.

Results

Accelerated Soft Tissue Healing

The CGF group demonstrated significantly faster soft tissue closure. At 7 days, the CGF group reached a healing rate of 60.51%, compared to 38.38% in the Bio-Gide group. By 14 days, the CGF group achieved 89.1% healing, while the Bio-Gide group lagged at 61.73% (P < 0.001).

Clinical Outcomes and Bone Preservation

Despite the differences in early soft tissue healing, both groups showed equivalent performance in bone preservation. At 6 months, bone resorption at 1 mm below the baseline was approximately 2 mm for both groups, indicating successful ridge preservation. Both groups also saw a comparable slight increase (~0.8–0.9 mm) in keratinized gingival width.

Clinical workflow of alveolar ridge preservation (ARP) using CGF membrane, from initial extraction to final prosthetic restoration.

Superior Vascularization

Histological analysis revealed that the CGF group had a significantly higher micro-vessel density (35.32 ± 3.47) compared to the Bio-Gide group (22.93 ± 4.42, P < 0.001). This suggests that CGF actively promotes angiogenesis, facilitating faster tissue repair through enhanced blood supply.

Discussion and Conclusion

CGF membranes offer a "living" biomaterial advantage over the purely physical barrier provided by traditional collagen membranes. By actively signaling cell migration and promoting rapid vascularization, CGF significantly accelerates early wound closure. Furthermore, as an autogenous material, CGF eliminates risks of cross-species infection and is highly cost-effective.

While the study is limited by a small sample size and the meticulous suturing required to handle the "slippery" CGF material, the results confirm that CGF is a reliable and effective alternative for sealing sockets in ARP. Future research should focus on larger cohorts and long-term implant success rates to further validate these findings.

Summary updated

Abstract

The purpose of this study was to evaluate the efficacy of concentrated growth factor (CGF) membrane for the sealing of alveolar socket in alveolar ridge preservation (ARP). A total of 22 patients with 24 alveolar sockets were recruited and divided randomly into CGF group and Bio-Gide collagen membrane group. The soft tissue wound healing rate was calculated using intraoral scanner at 3, 7, and 14 days after ARP, and the bone resorption volume at 1, 3, and 5 mm below the alveolar ridge was measured by CBCT at 6 months postoperation. The keratinized gingival width was also measured before and 6 months after ridge preservation. In terms of soft tissue healing rate, the CGF group exhibited significant higher than that of Bio-Gide group at both 7 and 14 days after surgery (P &lt; 0.05). However, there was no significantly different in bone resorption rate and the width of keratinized gingival after 6 months (P &gt; 0.05). Therefore, the use of CGFs membranes for wound closure in ARP is a reliable method, but more clinical data are needed to prove it.
BibTeX
@article{liu2022clinical,
  author = {Yumeng Liu and Xiaoming Li and Changwei Jiang and Huiying Guo and Guisheng Luo and Yangyang Huang and Changyong Yuan},
  title = {{Clinical applications of concentrated growth factors membrane for sealing the socket in alveolar ridge preservation: a randomized controlled trial}},
  journal = {International Journal of Implant Dentistry},
  year = {2022},
  doi = {10.1186/s40729-022-00448-w},
}
Figure